Prostasin (PRSS8), GSTT1, FOLR1, KLK6, KLK7, and ALDH1 are all currently under research and clinical trials (Table 2) and are also potential biomarkers for early detection of ovarian cancer. Here, PRSS8 is linked to ovarian carcinoma.